Patent · US Active

Medical treatments based on anamorelin

US10278964B2 · kind B2 · utility

3Cited by
4References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 9, 2017
Grant dateMay 7, 2019
Priority date
Expiry dateMay 9, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P39/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treating cancer related conditions using anamorelin are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.